Skip navigation
Facebook IPO
Symbol Lookup


Company: MannKind Corp

  • NEWS
MannKind Corp : [MNKD  Loading...      ()   ]
Thursday, 10 May 2012 | Source: The Associated Press
Shares of MannKind Corp. fell Thursday after the company said results from a trial of its inhaled diabetes drug Afrezza may be delayed by about three months.
Monday, 30 Apr 2012 | Source: The Associated Press
Diabetes drug developer MannKind Corp. said Monday that it is licensing a group of experimental drugs to Tolero Pharmaceuticals Inc. in a deal that could be worth more than $130 million.

POPULAR TAGS

More: Topics | Sectors | Companies
 

TOPICS

More
 


Current DateTime: 02:05:38 24 May 2012
LinksList Documentid: 23188555

 

SECTORS

More
 


Current DateTime: 02:05:38 24 May 2012
LinksList Documentid: 23188557

Current DateTime: 07:26:50 25 May 2012
LinksList Documentid: 29778429

Current DateTime: 05:24:27 25 May 2012
LinksList Documentid: 29778428

Current DateTime: 02:05:35 24 May 2012
LinksList Documentid: 29779196

Current DateTime: 03:09:12 25 May 2012
LinksList Documentid: 29779197

Current DateTime: 02:05:35 24 May 2012
LinksList Documentid: 29779200

Current DateTime: 01:52:52 25 May 2012
LinksList Documentid: 29779199

Current DateTime: 07:39:23 25 May 2012
LinksList Documentid: 29779198
CNBCCNBC
About CNBC  |  Site Map  |  Video Reprints   |  Advertise  |  Help  |  Contact
Privacy Policy  |     |  Terms of Service  |  Independent Programming Report
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC.  All Rights Reserved.
A Division of NBCUniversal
Thomson ReutersThomson Reuters